Stung by reports of backpedaling on a pledge to limit drug price hikes, AbbVie (ABBV) insisted on Tuesday that it will stick to just one, single-digit price increase next year.
The statement came a day after news reports — including ours — indicated the drug maker would abandon its commitment to keep all price increases below 10 percent and raise prices only once a year, although AbbVie maintained its pledge referred only to this year. The original source for the stories was a report from a Wall Street securities analyst, who summarized AbbVie remarks following a meeting with company management last week.
About the Author Reprints
